4.5 Conclusions
Animal models which mimic the hallmarks of human bronchial asthma are urgently needed. Such models provide important insight into the pathophysiology of the disease. However, the phenotype of such models must be carefully assessed. Most of the models currently available reflect the stage of acute asthmatic responses with airway inflammation, airway hyperresponsiveness, and sometimes mucus production. However, bronchial asthma represents a chronic disease with chronic and persistent airway inflammation, involvement of the smaller airways, structural changes within and beneath mucosal tissues, and persistent airway obstruction. Advances have been made in further developing models which mimic this phenotype much more closely. These models are particularly relevant in terms of developing novel therapeutic approaches for immuno-intervention in this complex disease. In the future it will be necessary to develop preventive strategies as well as strategies which specifically and sufficiently interfere in structural changes of the airways, since none of the currently available therapies are able to prevent or stop the beginning of airway remodeling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alarie Y (1966) Irritating properties of airborne materials to the upper respiratory tract. Arch Environ Health 13:433–449
Ambdur M, Mead J (1958) Mechanics of respiration in unanesthetized guinea-pigs. Am J Physiol 192:364–368
Beasley R, Roche WR, Roberts JA, et al (1989) Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139:806–817
Boggs D (1992) Comparative control of respiration. In Parent RA, Comparative biology of the normal lung. CRC Press, Boca Raton, pp 309–351
Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, et al (1990) Eosinophilic inflammation in asthma. N Engl J Med 323:1033–1039
Bradding P (1996) Human mast cell cytokines. Clin Exp Allergy 26:13–19
Braun A, Lommatzsch M, Mannsfeldt A, Neuhaus-Steinmetz U, Fischer A, Schnoy N, Lewin GR, Renz H (1999) Cellular sources of enhanced brain-derived neurotrophic factor (BDNF) production in a mouse model of allergic inflammation. Am J Respir Cell Mol Biol 21:537–546
von Bubnoff D, Novak N, Kraft S, Bieber T (2003) The central role of FcɛRI in allergy. Clin Exp Dermatol 28:184–187
Busse WW, Sedgwick JB (1994) Eosinophil eicosanoid relations in allergic inflammation of the airways. Adv Prostaglandin Thromboxane Leukot Res 22:241–249
Clutterbuck EJ, Sanderson CJ (1998) Human eosinophil hematopiesis studied in vitro by means of murine eosinophil differentiation factor (IL-5): production of functionally active eosinophils from normal human bone marrow. BMJ 71:646–651
Collins DS, Dupuis GJ, Gleich KR, Bartemes KR, Koh YY, Pollice M, Albertine KH, Fish JE, Peters SP (1993) Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation. Am Rev Respir Dis 147:677–683
Cookson W (1999) The alliance of genes and environment in asthma and allergy. Nature 402:B5–11
Corrigan CJ, Kay AB (1992) T cells and eosinophils in the pathogenesis of asthma. Immunol Today 13:501–507
Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, et al (1998) Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 4:344–355
Drazen JM, Arm JP, Austen KF (1996) Sorting out the cytokines of asthma. J Exp Med 183:1–5
Eckert R, Randall D (1988) Animal physiology-mechanisms and adaptions. WH Freeman and Company, San Francisco, pp 68–84
Ellis JL, Hubbard WC, Meeker S, et al (1994) Ragweed antigen E and anti-IgE in human central versus peripheral isolated bronchi. Am J Respir Crit Care Med 150:717–723
Finotto S, De Sanctis GT, Lehr HA, Herz U, Buerke M, Schipp M, Bartsch B, Atreya R, Schmitt E, Galle PR, Renz H, Neurath MF (2001) Treatment of allergic airway inflammation and hyperresponsiveness by antisense-in-duced local blockade of GATA-3 expression. J Exp Med 193:1247–1260
Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D, Kay AB (2003) Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112(7):1029–1036
Foster H (1983) The mouse in biomedical research, Vol III. Academic Press
Foster PS, Hogan SP, Ramsay EJ, Matthaei KI, Young IG (1996) Interleu-kin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183:195–201
Gavett SH, Chen X, Finkelman F, Wills-Karp M (1994) Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 10:587–593
Glaab T, Daser A, Braun Steinmetz-Neuhaus U, Fabel H, Alarie Y, Renz H (2001) Tidal midexpiratory flow as a measure of airway hyperresponsiveness in allergic mice. Am J Physiol Lung Cell Mol 280:L565–573
Gleich GJ, Adolphson CR, Leiferman KM (1993) The biology of the eosinophilic leukocyte. Annu Rev Med 44:85–101
Haley KJ, Sunday ME, Wiggs BR, Kozakewich HP, Reilly JJ, Mentzer SJ, Sugarbaker DJ, Doerschuk CM, Drazen JM (1998) Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 158:565–572
Hamelmann E, et al (1997) Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156:766–775
Hegele RG, Hogg JC (1996) The pathology of asthma: an inflammatory disorder. In: Szefler SJ, Leung DYM (eds) Severe asthma: pathogenesis and clinical management. Marcel Dekker, New York, pp 61–76
Hertz M, Mahalingam S, Dalum I, Klysner S, Mattes J, Neisig A, Mouritsen S, Foster PJ, Gautam A (2001) Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J Immunol 167:3792–3799
Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS (1997) Aeroaller-gen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 99:1329–1339
Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS (1998a) Interleu-kin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 157:210–218
Hogan SP, Mathtaei KI, Young JM, Koskinen A, Young IG, Foster PS (1998b) A novel T cell-regulated mechanism modulating allergen-induced hyperreactivity in BLAB/c mice independently of IL-4 and IL-5. J Immunol 161:1501–1509
Hogg JC (1993) The pathology of asthma. In: Holgate ST, Austen KF, Lich-tenstein LM, et al (eds) Asthma: physiology, immunopharmacology and treatment. Academic Press, London, pp 17–25
Holz O, Jorres RA, Magnussen H (2000) Monitoring central and peripheral airway inflammation in asthma. Respir Med 94:S7–12
Izuhara K, Arima K, Yasunaga S (2002) IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr Drug Targets Inflamm Allergy 1:263–269
James AL, Pare PD, Hogg JC (1989) The mechanics of airway narrowing in asthma. Am Rev Respir Dis 139:242–246
Kaminuma O, Mori A, Ogawa K, Nakata A, Kikkawa H, Naito K, Suko M, Okudaira H (1997) Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Bid 16:448–454
Kanehiro A, Ikemura T, Makela MJ, Lahn M, Joetham A, Dakhama A, Gelfand EW (2001) Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med 163:173–184
Kenyon NJ, Ward RW, Last JA (2003) Airway fibrosis in a mouse model of airway inflammation. Toxicol Appl Pharmacol 186:90–100
Kerzel S, Päth G, Nockher WA, Quarcoo D, Raap U, Groneberg DA, Thai Dinh Q, Fischer A, Braun A, Renz H (2003) Pan-Neurotrophin Receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am J Respir Cell Mol Biol 28:170–178
Kinet JP (1990) The high-affinity receptor for immunoglobulin E. Curr Opin Immunol 2:499–505
Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG (1997) Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185:885–892
Kraft M (1999) The distal airways: are they important in asthma? Eur Respir J 14:1403–1417
Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, et al (1997) Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomic of asthma. J Exp Med 185:2143–2156
Leff AR (1994) Inflammatory mediation of airway hyperresponsiveness by peripheral blood granulocytes: the case for the eosinophil. Chest 106:1202–1208
Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA (1988) Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167:219–224
Lungarella G, Menegazzi R, Gardi C, Spessotto M, de Santi M, Bertocin P, Patriarca P, Calzoni P Zabucchi G (1992) Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch Biochem Biophys 292:128–135
Marthur M, Herrmann K, Li X, Qin Y, Weinstock J, Elliott D, et al (1999) TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am J Respir Crit Care Med 159:580–587
Neuhaus-Steinmetz U, Glaab T, Daser A, Braun A, Lommatzsch M, Herz U, Kips J, Alarie Y, Renz H. (2000) Sequential development of airway hyperresponsiveness and acute airway obstruction in a mouse model of allergic inflammation. Int Arch Allergy Immunol 121(l):57–67
Oh SW, Pae CI, Lee DK, Jones F, Chiang GK, Kim HO, Moon SH, Cao B, Ogbu C, Jeong KW, Kozu G, Nakanishi H, Kahn M, Chi EY, Henderson WR (2002) Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 168:1992–2000
Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, Denburg J, Harley CB, Gauldie J, Jordana M (1992) Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 89:1662–1668
Palmans E, Kips JC, Pauwels RA (2000) Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 161:627–635
Päth G, Braun A, Meents N, Kerzel S, Raap U, Hoyle GW, Nockher WA, Renz H (2002) Augmentation of allergic early-phase reaction by Nerve Growth Factor (NGF). Am J Respir Crit Care Med 166:818–826
Rabe KF, Munoz NM, Vita AJ, Morton BE, Magnussen H, Leff AR (1994) Contraction of human bronchial smooth muscle caused by activated human eosinophils. Am J Physiol 267:L326–334
Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW (1992) Aerosolized antigen exposure without adjuvant causes increased IgE production and airways hyperresponsiveness in the mouse. J All Clin Immunol 89:1127–1138
Renz H, Or R, Domenico J, Leung DYM, Gelfand EW (1992) Reciprocal regulatory effects of IL-4 on cell growth and immunoglobulin production in Ig-secreting human B-cell lines. Clin Immunol Immunopathol 64:233–241
Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB (1992) Predominant TH2-like broncho-alveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298–304
Sakai K, Yokohama A, Kouno N, Hamada H, Hiwada K (2001) Prolonged antigen exposure ameliorates airway inflammation but not remodelling in a mouse model of bronchial asthma. Int Arch Allergy Immunol 126:126–134
Sanderson CJ (1988) Interleukin-5: an eosinophil growth and activation factor. Dev Biol Stand 69:23–29
Sanderson CJ (1990) The biological role of interleukin 5. Int J Cell Cloning 8:147–153
Shi HZ, Xiao CQ, Zhong D, Qin SM, Liu Y, Liang GR, Xu H, Chen YQ, Long XM, Xie ZF (1998) Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 157:204–209
Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF (2000) Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 105:945–953
Temelkowski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK (1998) An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53:849–856
Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, Bousquet J (1998) Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 157:403–440
Vijayaraghanavan R, Schaper M, Thompson R, Stock MF, Alarie Y (1993) Characteristic modifications of the breathing pattern of mice to evaluate the effects of airborne chemicals on the respiratory tract. Arch Toxicol 67:478–490
Wagner EM, Bleecker ER, Permutt S, et al (1998) Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 157:447–452
Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B (1994) Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 150:1038–1048
Walz TM, Nishikawa BK, Malm C, Wasteson A (1993) Production of transforming growth factor alpha by normal human blood eosinophils. Leukemia 7:1531–1537
Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A (1989) Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 19:701–705
Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD (1998) Interleukin-13: central mediator of allergic asthma. Science 282:2258–2261
Yanai M, Sekizawa K, Ohrui T, et al (1992) Site of airway obstruction in pulmonary disease; direct measurement of intrabronchial pressure. J Appl Physiol 72:1016–1023
Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB (1995) Phenotype of cells expressing mRNA for Th2-type (interleukin 4 and interleukin 5) and Thl-type (interleukin 2 and interferon gamma) cytokines in broncho-alveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects. Am J Respir Cell Mol Biol 12:477–487
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wegmann, M., Renz, H. (2005). Animal Models of Experimental Asthma. In: Zollner, T., Renz, H., Asadullah, K. (eds) Animal Models of T Cell-Mediated Skin Diseases. Ernst Schering Research Foundation Workshop, vol 50. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26811-1_4
Download citation
DOI: https://doi.org/10.1007/3-540-26811-1_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21067-2
Online ISBN: 978-3-540-26811-6
eBook Packages: MedicineMedicine (R0)